Additionally, the presence of Roseburia intestinalis or butyrate significantly enhances the effectiveness of anti-PD-1 immunotherapy in mice with CRC exhibiting microsatellite instability (MSI)-low (28). The gene discussed is PDCD1; the disease is colorectal carcinoma.